Unlike large-cap names covered by dozens of analysts, UVE carries very thin formal coverage. The only current, attributable price target is Piper Sandler's $51, maintained with a Neutral rating by analyst Paul Newsome, who raised it from $45 in late October 2026. That single figure sits just under 10% above the prevailing share price, and a single target does not constitute a reliable aggregate. For that reason, this article uses a fallback objective of $55, a psychological round number and a natural technical-extension level tied to a breakout above the $50.75 52-week high. The $55 figure should be understood as a publicly discussed technical milestone, not an analyst consensus or a formal price forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At a recent close near $46.47, UVE would need to gain about $8.53, or roughly 18%, to reach $55. That is a substantial move, especially for a stock that has already appreciated sharply and now trades within roughly 10% of its 52-week high of $50.75. The path would likely run through two stages: first, reclaiming and holding above the $50.75 high, and second, establishing acceptance above the $51 analyst mark that has functioned as a near-term reference point. Fundamentals provide some fuel: the company's most recent quarter featured EPS of $1.93 that beat estimates of about $1.57, aided by lower loss ratios from reduced cession and by strong premium growth outside its core Florida market. Trailing profitability remains robust, with return on equity near 38–40% and a net margin around 14%.
The clearest technical hurdle is the 52-week high of $50.75, which has acted as resistance and sits just above the $51 analyst target. A decisive break above that zone would open a measured path toward the $55 psychological level. On the downside, the 50-day simple moving average near $44.80 offers the first major support, with the 200-day average near $38.80 providing a deeper floor. The stock's longer-term trend remains constructive after the run from the mid-$20s, but the distance above the 200-day average also suggests the shares are extended and could consolidate before any further leg higher. One thing that stands out here is how the recent momentum aligns with patterns I reviewed via Tickeron’s AI Real Time Patterns.
Published analyst targets, including Piper Sandler's $51, typically reflect a research horizon of roughly 12 months, though no firm timetable is attached to the technical $55 objective. Investors should watch quarterly earnings and catastrophe-loss reports, premium growth outside Florida, and any changes to reinsurance costs. Analyst rating changes, updates to Piper Sandler's target, and sector-wide signals on Florida insurance pricing will also matter. Broader interest-rate moves and the trajectory of the hurricane season remain important external variables for a property insurer. I'm watching this closely as earnings season unfolds.
The $55 objective is an ambitious but not unreasonable technical extension for Universal Insurance Holdings, implying roughly 18% upside from current levels and requiring a breakout above the $50.75 52-week high. The case rests on improving underwriting, geographic diversification, cheap valuation, and renewed capital returns. The counterarguments are equally real: hurricane exposure, possible pricing compression, an uneven top line, and a stock that has already run far ahead of its long-term averages. With only one current analyst price target, investors should treat $55 as a directional milestone rather than a guaranteed outcome, and monitor earnings, catastrophe losses, and premium growth before drawing conclusions.
In my research process, Tickeron’s AI Daily Buy/Sell Signals provide a useful way to track momentum shifts across thousands of stocks and ETFs using AI-driven analysis of technical behavior and market conditions. For a name like UVE with volatile price action and limited analyst coverage, these signals offer an efficient way to monitor positions and spot potential changes without relying solely on traditional sources.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Stochastic Oscillator for UVE moved into oversold territory on November 09, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The 10-day moving average for UVE crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +3.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where UVE advanced for three days, in 240 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 199 of 289 cases where UVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
The 10-day RSI Indicator for UVE moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 26 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UVE as a result. In 52 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for UVE turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 28 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
UVE broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock better than average.
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.848) is normal, around the industry mean (-2.070). P/E Ratio (5.558) is within average values for comparable stocks, (9.942). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (3.303). Dividend Yield (0.015) settles around the average of (0.027) among similar stocks. P/S Ratio (0.784) is also within normal values, averaging (1.594).
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. UVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiaries provides property and casualty insurance services
Industry PropertyCasualtyInsurance